International Biotech Expansion Marks Major Milestone for Albany’s Life Sciences Growth

Albany, NY — April 17, 2026 — The company has selected 150 New Scotland Avenue in Albany as the location for its first U.S. operation, bringing new investment, high-quality jobs, and international recognition to the Capital Region.

The addition of One Biosciences represents an important advancement for the region’s expanding life sciences ecosystem. With plans to invest $18 million and create 42 new jobs over the next five years, the company’s decision to establish operations in Albany reflects the growing strength of the market as a destination for research, innovation, and specialized medical technology.

Located within the Life Sciences Innovation Building on the campus of the Albany College of Pharmacy and Health Sciences, One Biosciences joins a collaborative environment designed to support scientific advancement and biotech growth. The facility has evolved into a center for innovation, bringing together research organizations, emerging companies, and educational institutions in one strategic location.

For First Columbia, the arrival of One Biosciences marks the completion of a significant repositioning effort at 150 New Scotland Avenue. Through strategic redevelopment, leasing, and tenant collaboration, the 150,000-square-foot property has been transformed into a fully occupied life sciences destination that supports innovation and long-term economic development.

“This is exactly the kind of momentum we envisioned for the property,” said Kevin Bette, Partner at First Columbia. “Welcoming an international biotech company like One Biosciences to 150 New Scotland is a strong validation of the collaborative environment we’ve worked to create.”

The company’s leadership explored opportunities throughout the Northeast before selecting Albany, recognizing the value of the region’s growing life sciences network, institutional partnerships, and the support infrastructure available at the property. Their decision to choose Albany over larger metropolitan markets demonstrates the Capital Region’s increasing competitiveness in attracting innovative firms on a global scale.

This milestone also reinforces the broader growth of the Capital Region’s life sciences industry, supported by world-class employers, research institutions, and public investment initiatives. As demand for specialized lab and research environments continues to rise, properties that can deliver purpose-built space within an innovation-focused ecosystem are becoming increasingly valuable.

At First Columbia, we are proud to play a role in fostering that growth. The successful transformation of 150 New Scotland Avenue and the arrival of One Biosciences underscore the importance of strategic real estate investment in building the environments where innovation thrives.

As Albany continues to attract pioneering companies and top-tier talent, the Capital Region is solidifying its place as a premier destination for life sciences investment—and First Columbia remains committed to helping drive that momentum forward.